Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of GSK2838504A vaccine in adults with COPD
2013-003062-13Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in chronic obstructive pulmonary disease (COPD) comparing GSK2838504A vaccine with Placebo (2 arms). Primary endpoint: Occurrence of each solicited local adverse event. Started Nov 2013; status: completed.
02
Drugs
NTHi-10-AS01E
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-003062-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003062-13.